FRONT END UI/UX ENGINEER
Chris has a background in graphic design. Using this, he helps to facilitate collaboration between Apricity’s application design and engineering, re-imagine and create the user interface/user experience, and finalize promotional materials.
. . . been a board member and/or strategic financial advisor to the Merck Global Health Innovation Fund, one of the leading venture funds in digital health, and many digital health companies ranging from pain management, mindfulness, schedule optimization, mental health, and substance use disorder.
Raphael Chancey has a long track record of leading multidisciplinary teams to develop technologies for transformational uses. Prior to joining Apricity, he was the Director of IBM Watson Innovation Labs in Austin, TX where he was responsible for researching, innovating and advancing various cognitive and AI technologies for Watson. Recently he led his team to conceive and create an embodied cognition platform called Intu that prototyped Watson as the brain/intelligence of Robots. Before his . .
. . . involvement with Watson Labs, he was the Chief Architect for BPO Accelerators that focused on developing cloud-based deployment patterns bundling IBM Products that seamlessly scaled to production level environments. He had also led a global SOA Advanced Technology team that focused on building enterprise class solutions, applications and tooling across various industries. He has filed over 20 patents and served in the United States Army as a Combat Engineer.
Lynda Chin, MD
An elected member of the National Academy of Medicine, Dr. Chin is a renowned cancer genomic scientist and a leader in the application of analytical technologies, AI/ML, and big data in medicine. Her groundbreaking work synthesizing terabyte-scale datasets in genomics and oncology research has opened new frontiers in digital medicine.
As founding chair of the Department of Genomic Medicine at the University of Texas MD Anderson Cancer Center, Dr. Chin launched projects to transform workflows for patient-oriented research, . . .
. . . harness high-velocity clinical and research data, and democratize cancer care expertise across a network of global partner care centers. As Chief Innovation Officer of the University of Texas System, she forged initiatives to create infrastructure for more equitable access to care for underserved populations. In her work at The Cancer Genome Atlas (TCGA), she was Principal Investigator driving development of the Firehose data pipeline, served on the Scientific Steering Committee of the International Cancer Genome Consortium (ICGC), and is actively involved in conceptualizing the next phase of ICGC, ICGC-ARGO (Accelerating Research on Genomic Oncology).
Dr. Chin earned a B.A. degree from Brown University and a M.D. degree from Albert Einstein College of Medicine. She conducted her clinical and scientific training at Columbia Presbyterian Medical Center and Montefiore Medical Center in NY and went on to a productive academic research career at Dana-Farber Cancer Institute, where she was a professor at Harvard Medical School and a senior associate member at the Broad Institute of MIT and Harvard.
Mary Alice Fulmer, DNP, APRN-C
CLINICAL CONTENT SPECIALIST
Mary Alice ensures our clinical content is up to date and evidence based Her background is cardio-thoracic surgery and gynecology. She has a degree in doctor of nursing practice, which includes both clinical and research components.
CUSTOMER CARE SPECIALIST
Bio coming soon
CHIEF SECURITY OFFICER
With over 20 years of experience in digital transformation, Fintech, Regtech, Cybersecurity, regulatory compliance and data management, Joonho brings significant digital security and data privacy expertise to Apricity Health.
He is a co-founder and CEO of TalisAI Inc., an accountable and explainable Artificial /Augmented Intelligence (AI) company providing solutions to protect modern business from insidious threats from data, algorithms and people. Before TalisAI, he . . .
. . . held various leadership roles in the Federal Reserve Bank of New York and San Francisco, including Sr. VP & Chief Information Officer and Head of Strategy & Operations. He also instituted and led the national cybersecurity response unit protecting the Federal Reserve System and the U.S. Department of the Treasury from the cyber threats.
Joonho received his J.D. from New York Law School. He holds M.B.A and M.S. degrees both from Rensselaer Polytechnic Institute, as well as a B.S. in computer engineering from the University of Connecticut. He is admitted to New York State bar as an attorney specializing in information law and policy.
Richard Lyle worked for over 22 years in the game industry. In that period of time, he was involved in the development of 13 published commercial products for XBOX, PC, PlayStation, iOS, Android, and 3DO. He started programming at the age of 13 and submitted his first game for publication at the age of 17. He founded his own game company, Palestar, in 1999, and successfully developed and published one of the first . . .
. . . generation of massively multiplayer games in 2001. In 2016 he joined the IBM innovation lab where he was the lead developer for “Project Intu”, a cognitive embodiment middle-ware for AI, working hand in hand with the legendary Grady Booch, an icon in the field of computer science. Richard has multiple patents in the field of artificial intelligence.
SENIOR FRONT END ENGINEER
Ginny has a background in molecular biology and she has brought that focused mind into her new passion for coding online solutions. She is responsible for selecting, installing, developing and testing the user interface elements of a website.
Director of Operations and Compliance Support
Rick Mohan is a video game industry veteran of over 17 years spanning across both North America and Asia. Having developed and operated some of the longest running massively multiplayer online games to date with as many as 35 million active subscribers, he knows large scale complex customer focused products. He also started his own studio building a DRM digital distribution platform which spanned Greater South Asia which was acquired 5 years later, prompting his return to the states.
QUALITY ASSURANCE AND SECURITY COMPLIANCE SPECIALIST
Aaliyah is responsible for testing and debugging ApricityCare products to ensure they meet standards and guidelines and are ready for consumer markets. Prior to working with Apricity, Aaliyah served as program director for youth development programs under the Office of the Attorney General and later as a producer/director for various television and film projects.
Shyamali Singhal, MD/PhD
As a leader in the fields of surgical oncology and general surgery, Dr. Shyamali Singhal is no stranger to the medical world and the lives her patients lead while under her care. At the beginning of her career, Dr. Singhal focused primarily on bench-to-bedside, studying drug resistance to chemotherapeutic agents such as taxol before shifting her focus from medicine to surgery. After finishing her fellowship in . . .
. . . surgical oncology, Dr. Singhal was offered the opportunity to serve as the Medical Director at the El Camino Hospital Cancer Center in Silicon Valley, which at the time had no available organized cancer services.
As a general surgeon and surgical oncologist with over twenty years of medical experience, Dr. Singhal has borne witness to the will and power which is needed in order to tolerate and overcome chemotherapy through the lives of her patients, and understands that being a great surgeon is just as important as being a great listener. She has developed a multidisciplinary approach to cancer treatment that involves not only chemotherapy, radiation, and surgery but working closely with patients to focus on the treatment of their bodies during and after the chemotherapy process.
The importance of working with a surgical oncologist such as Dr. Singhal is well documented, and since these specific oncologists have at least an additional three years of fellowship training in all cancers in order to diagnose, biopsy and surgically treat cancers of all types, they have been scientifically proven to improve your outcomes and chances of survival in even the most challenging circumstances.
As a surgeon with legitimate experience and interests in adjuvant chemotherapy and immunotherapy, Dr. Singhal is one of the rare doctors that knows precisely which decisions to make under any given surgical situation. Under Dr. Singhal’s leadership, the Cancer Center at El Camino Hospital now admits over 2,000 new patients a year with twenty-five percent of patients commuting from outside Silicon Valley and staying at the center for every phase of care.
In addition to her work as Executive Director of the Cancer Center at El Camino Hospital, Dr. Singhal graduated from John Hopkins University in Baltimore, Maryland and the Albert Einstein College of Medicine in New York City, where she received her M.D. as well as her PhD. in Molecular Pharmacology. After completing her surgical residency at the University of Washington, she finished a post-residency fellowship in surgical oncology at the City of Hope National Cancer Center in Duarte, California.
FULL STACK ENGINEER
Shawn works on creating Apricity’s client facing software as well as assisting in improving Apricity’s internal tools.
Daniela Treitl, MD
ASSISTANT MEDICAL DIRECTOR, VP OF CLINICAL DEVELOPMENT
Daniela Treitl is a licensed physician with a medical degree from NYU, and post-graduate surgical training at Mount Sinai Medical Center with sub-specialty training in endocrine surgery at University of California San Francisco. Using her clinical experience, particularly in the area of oncology, Dr. Treitl is responsible for the accuracy and validity of the clinical content and in the development of the knowledge models. Dr. Treitl is also an expert in ApricityRosetta, and in her role as VP of Clinical Development and Assistant Medical Director, has successfully developed and implemented a COVID-19 knowledge model into the Apricity@Work solution.
Keli is a partner at Duane Morris LLP, where she represents clients in connection with corporate and securities transactions, focusing on venture capital, public and private securities offerings, mergers and acquisitions and the representation of emerging growth and middle market companies. Keli represents a number of leading venture capital firms and angel investors.
In 2005, Keli was named one of the “40 Under 40” outstanding business leaders in . . .
. . . Baltimore by the Baltimore Business Journal
Keli is a 1997 graduate, with honors, of the University of Maryland School of Law, where she was elected to the Order of the Coif, and a graduate, with honors, of Goucher College.